Cogent Biosciences (COGT) EPS (Basic) (2017 - 2026)
Cogent Biosciences (COGT) recorded quarterly EPS (Basic) of -$0.53 in Q1 2026, up 13.11% quarter-over-quarter from -$0.61 in Q4 2025, and down 1.92% on a YoY basis from -$0.54 in Q1 2025.
Cogent Biosciences (COGT) EPS (Basic) (2017 - 2026) Analysis & Trends
Cogent Biosciences' EPS (Basic) history runs 10 years deep, the most recent figure standing at -$0.53 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 1.92% year-over-year to -$0.53; the TTM figure through Mar 2026 stood at -$2.17 (down 10.15% YoY), while the FY2025 annual figure was -$2.16, down 11.34% from the prior year.
- EPS (Basic) was -$0.53 for Q1 2026 at Cogent Biosciences, up from -$0.61 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.11 in Q4 2022 to a low of -$575.52 in Q2 2023.
- Historically, EPS (Basic) has averaged -$34.32 across 5 years, with a median of -$0.52 in 2023.
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) surged 117.74% in 2022, then slumped 80959.49% in 2023.
- A 5-year view of EPS (Basic) shows it stood at $0.11 in 2022, then tumbled by 572.73% to -$0.52 in 2023, then advanced by 3.85% to -$0.5 in 2024, then dropped by 22.0% to -$0.61 in 2025, then advanced by 13.11% to -$0.53 in 2026.
- The last three EPS (Basic) figures came in at -$0.53 (Q1 2026), -$0.61 (Q4 2025), and -$0.5 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 0.00 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 0.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -0.06 |
| 10 | Cogent Biosciences | 5.19 Bn | 4.32 Bn | - | -0.53 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.53 |
| Dec 31, 2025 | -0.61 |
| Sep 30, 2025 | -0.50 |
| Jun 30, 2025 | -0.53 |
| Mar 31, 2025 | -0.52 |
| Dec 31, 2024 | -0.50 |
| Sep 30, 2024 | -0.52 |
| Jun 30, 2024 | -0.43 |
| Mar 31, 2024 | -0.49 |
| Dec 31, 2023 | -0.52 |
| Sep 30, 2023 | -0.53 |
| Jun 30, 2023 | -575.52 |
| Mar 31, 2023 | -0.42 |
| Dec 31, 2022 | 0.11 |
| Sep 30, 2022 | -0.50 |
| Jun 30, 2022 | -0.71 |
| Mar 31, 2022 | -0.68 |
| Dec 31, 2021 | -0.62 |
| Sep 30, 2021 | -0.48 |
| Jun 30, 2021 | -0.43 |